Literature DB >> 18799455

Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7.

Christopher D Lima1, David Reverter.   

Abstract

Small ubiquitin-like modifier (SUMO) proteases regulate the abundance and lifetime of SUMO-conjugated substrates by antagonizing reactions catalyzed by SUMO-conjugating enzymes. Six SUMO proteases constitute the human SENP/ULP protease family (SENP1-3 and SENP5-7). SENP6 and SENP7 include the most divergent class of SUMO proteases, which also includes the yeast enzyme ULP2. We present the crystal structure of the SENP7 catalytic domain at a resolution of 2.4 angstroms. Comparison with structures of human SENP1 and SENP2 reveals unique elements that differ from previously characterized structures of SUMO-deconjugating enzymes. Biochemical assays show that SENP6 and SENP7 prefer SUMO2 or SUMO3 in deconjugation reactions with rates comparable with those catalyzed by SENP2, particularly during cleavage of di-SUMO2, di-SUMO3, and poly-SUMO chains composed of SUMO2 or SUMO3. In contrast, SENP6 and SENP7 exhibit lower rates for processing pre-SUMO1, pre-SUMO2, or pre-SUMO3 in comparison with SENP2. Structure-guided mutational analysis reveals elements unique to the SENP6 and SENP7 subclass of SENP/ULP proteases that contribute to protease function during deconjugation of poly-SUMO chains.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18799455      PMCID: PMC2581585          DOI: 10.1074/jbc.M805655200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast.

Authors:  E Mossessova; C D Lima
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

2.  Association of the human SUMO-1 protease SENP2 with the nuclear pore.

Authors:  Jun Hang; Mary Dasso
Journal:  J Biol Chem       Date:  2002-03-14       Impact factor: 5.157

3.  A novel mammalian Smt3-specific isopeptidase 1 (SMT3IP1) localized in the nucleolus at interphase.

Authors:  T Nishida; H Tanaka; H Yasuda
Journal:  Eur J Biochem       Date:  2000-11

4.  Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.

Authors:  Hong Zhang; Hisato Saitoh; Michael J Matunis
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

5.  A new protease required for cell-cycle progression in yeast.

Authors:  S J Li; M Hochstrasser
Journal:  Nature       Date:  1999-03-18       Impact factor: 49.962

6.  Polymeric chains of SUMO-2 and SUMO-3 are conjugated to protein substrates by SAE1/SAE2 and Ubc9.

Authors:  M H Tatham; E Jaffray; O A Vaughan; J M Desterro; C H Botting; J H Naismith; R T Hay
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

7.  Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.

Authors:  H Saitoh; J Hinchey
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

8.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

9.  Identification and characterization of DEN1, a deneddylase of the ULP family.

Authors:  Tudeviin Gan-Erdene; Kolli Nagamalleswari; Luming Yin; Kenneth Wu; Zhen-Qiang Pan; Keith D Wilkinson
Journal:  J Biol Chem       Date:  2003-05-19       Impact factor: 5.157

10.  Positive and negative regulation of APP amyloidogenesis by sumoylation.

Authors:  Yonghong Li; Hui Wang; Su Wang; Diana Quon; Yu-Wang Liu; Barbara Cordell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-27       Impact factor: 11.205

View more
  58 in total

Review 1.  Trojan horse strategies used by pathogens to influence the small ubiquitin-like modifier (SUMO) system of host eukaryotic cells.

Authors:  Miklós Békés; Marcin Drag
Journal:  J Innate Immun       Date:  2012-01-03       Impact factor: 7.349

Review 2.  The fate of metaphase kinetochores is weighed in the balance of SUMOylation during S phase.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Cell Cycle       Date:  2010-08-09       Impact factor: 4.534

3.  In Vitro Studies Reveal a Sequential Mode of Chain Processing by the Yeast SUMO (Small Ubiquitin-related Modifier)-specific Protease Ulp2.

Authors:  Julia Eckhoff; R Jürgen Dohmen
Journal:  J Biol Chem       Date:  2015-04-01       Impact factor: 5.157

Review 4.  An additional role for SUMO in ubiquitin-mediated proteolysis.

Authors:  Marie-Claude Geoffroy; Ronald T Hay
Journal:  Nat Rev Mol Cell Biol       Date:  2009-05-28       Impact factor: 94.444

Review 5.  SUMO rules: regulatory concepts and their implication in neurologic functions.

Authors:  Mathias Droescher; Viduth K Chaugule; Andrea Pichler
Journal:  Neuromolecular Med       Date:  2013-08-30       Impact factor: 3.843

Review 6.  SUMOylation and deSUMOylation at a glance.

Authors:  Yonggang Wang; Mary Dasso
Journal:  J Cell Sci       Date:  2009-12-01       Impact factor: 5.285

7.  The dynamics and mechanism of SUMO chain deconjugation by SUMO-specific proteases.

Authors:  Miklós Békés; John Prudden; Tharan Srikumar; Brian Raught; Michael N Boddy; Guy S Salvesen
Journal:  J Biol Chem       Date:  2011-01-19       Impact factor: 5.157

8.  Swapping small ubiquitin-like modifier (SUMO) isoform specificity of SUMO proteases SENP6 and SENP7.

Authors:  Kamela O Alegre; David Reverter
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

9.  Binding to small ubiquitin-like modifier and the nucleolar protein Csm1 regulates substrate specificity of the Ulp2 protease.

Authors:  Claudio Ponte de Albuquerque; Raymond T Suhandynata; Christopher R Carlson; Wei-Tsung Yuan; Huilin Zhou
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

10.  Identification and developmental expression of Xenopus laevis SUMO proteases.

Authors:  Yonggang Wang; Debaditya Mukhopadhyay; Smita Mathew; Takashi Hasebe; Rachel A Heimeier; Yoshiaki Azuma; Nagamalleswari Kolli; Yun-Bo Shi; Keith D Wilkinson; Mary Dasso
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.